Cargando…
A modular biomimetic strategy for the synthesis of macrolide P-glycoprotein inhibitors via Rh-catalyzed C-H activation
One of the key challenges to overcome multidrug resistance (MDR) in cancer is the development of more effective and general strategies to discover bioactive scaffolds. Inspired by natural products, we describe a strategy to achieve this goal by modular biomimetic synthesis of scaffolds of (Z)-allyli...
Autores principales: | Chen, Lu, Quan, Haitian, Xu, Zhongliang, Wang, Hao, Xia, Yuanzhi, Lou, Liguang, Yang, Weibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195407/ https://www.ncbi.nlm.nih.gov/pubmed/32358512 http://dx.doi.org/10.1038/s41467-020-16084-0 |
Ejemplares similares
-
Modular Synthesis of
Highly Substituted 3-Azapyrroles
by Rh(II)-Catalyzed N–H Bond Insertion and Cyclodehydration
por: Williams, Matthew B., et al.
Publicado: (2022) -
NL-103, a novel dual-targeted inhibitor of histone deacetylases and hedgehog pathway, effectively overcomes vismodegib resistance conferred by Smo mutations
por: Zhao, Jie, et al.
Publicado: (2014) -
Biomimetic Synthesis of Resveratrol Trimers Catalyzed by Horseradish Peroxidase
por: Zhang, Jian-Qiao, et al.
Publicado: (2017) -
Third‐generation EGFR inhibitor HS‐10296 in combination with famitinib, a multi‐targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR‐mutant non‐small cell lung cancer cells
por: Zhang, Mi, et al.
Publicado: (2021) -
Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants
por: Zhao, Jie, et al.
Publicado: (2014)